NEUP vs YUM · rev $15.7M vs P/E 29, rev $2.17B
Neuphoria Therapeutics Inc (NEUP) versus Yum! Brands Inc (YUM) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Yum! Brands Inc (YUM) is a restaurants company listed on US.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported YUM revenue for 2026-06-30 was $2.17B. Net income was $853.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
NEUP currently screens at market cap $23.6M. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
Not investment advice. Open the NEUP and YUM stock pages for the full models.
Not investment advice.